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During an immune response T cells prolifer-
ate, diff  erentiate, and give rise to memory cells. 
The signals driving the former two processes 
are reasonably well characterized; however, 
the identity of the costimulatory molecules in-
volved in generating memory cells is still not 
clear. CD40 is a member of the TNFR fam-
ily and is expressed on activated DCs and B 
cells (1). It binds to CD154 on activated T cells 
and is an initiator of the cross-talk between 
T cells and APCs (2, 3). CD40 acts as a mas-
ter regulator of APC function, inducing DC 
maturation and cytokine production (4–6), and 
consequently the interaction between CD154 
(CD40-ligand) and CD40 is critical for the de-
velopment of a mature immune response.
Studies in CD40KO and CD154KO mice 
have provided insights into the role of CD40–
CD154 interactions in T cell priming. There 
have been reports of reduced CD4 and CD8 T 
cell priming (7); however, others have found 
a defect only in the CD4 response (8) or no 
defect at all in the T cell response (9). These 
variations perhaps refl  ect the diff  erent immuni-
zation strategies used and inherent diff  erences 
between viral infection and protein-based 
  immunizations. Moreover, the CD4 T cell re-
sponse has primarily been examined indirectly 
using in vitro proliferation assays. Studies in-
volving the adoptive transfer of CD154KO 
TCR transgenic cells showed that, at this high 
precursor frequency, the KO cells can prolifer-
ate in vivo; however, the response was aborted 
at an early stage (6, 10). Similarly, exogenous 
CD40-  defi  cient DCs failed to sustain T cell 
activation after transfer to WT mice (10, 11). 
The importance of CD40 in the reactivation 
of memory T cell responses has not so far 
been defi  ned.
In this study, class II tetramers were used to 
track antigen-specifi  c responses generated by 
immunization with peptide emulsifi  ed in CFA 
or by peptide-pulsed bone marrow–derived 
DCs. Class II tetramers provide an elegant and 
physiological means to investigate CD4 T cell 
memory, enabling the ex vivo examination 
of endogenously generated antigen-specifi  c T 
cells for periods in excess of 200 d after im-
munization. CD40–CD154 interactions were 
required for both the priming of naive cells 
and the formation of memory cells. However, 
once a population of antigen-specifi  c memory 
cells had formed, CD40 signals were not re-
quired for either their maintenance or their 
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proliferation. The CD40–CD154 costimulatory signals were 
required, however, for the diff  erentiation of IFN-γ–produc-
ing eff  ector T cells. These data suggest that CD40–CD154 
interactions regulate primary and memory T cell responses 
in diff  erent ways. Specifi  cally, although primary CD4 T cells 
require CD40–CD154 interactions for expansion, memory 
T cells can survive and expand in a CD40–CD154-indepe-
ndent fashion but do require CD40–CD154 interactions for 
full eff  ector cell diff  erentiation.
RESULTS
Phenotypic characterization of peptide-induced 
antigen-specifi  c CD4 T cells
We used MHC class II tetramers to track antigen-specifi  c T 
cells through expansion and contraction phases of the re-
sponse and into the subsequent memory phase. The I-Ab class 
II tetramers (12) contain the peptide from the immunodomi-
nant epitope, H19-Env, from the envelope protein of mu-
rine Moloney leukemia virus (13). C57BL/6 mice were 
immunized with H19-Env delivered either in CFA or on 
peptide-pulsed bone marrow–derived DCs.
After immunization with H19-Env-CFA, the peak of the 
H19-Env–specifi  c CD4+ T cell response was between days 8 
and 10 at around 0.5% of CD4 cells (Fig. 1 A). Background 
staining was set by the level of tetramer binding in mice im-
munized with an irrelevant peptide, OVA323–339, in CFA, also 
shown in Fig. 1 A. Typically, this level of staining was below 
0.1% of total CD4+ cells. After day 8, a contraction phase 
followed that left  0.15% tetramer-binding cells, corre-
sponding to  104 total cells, in the spleen. The percentage 
and number of specifi  c cells remained above background for 
at least 229 d after immunization in the draining LN. In the 
spleen, tetramer+ cells were visible on day 176, but tetramer 
staining had fallen to background levels by day 229 (Fig. 1 A). 
In contrast, after transfer of peptide-pulsed DCs, the response 
peaked at around 0.2% of CD4 T cells and had dropped to 
background levels (mice immunized with OVA peptide–
pulsed DCs) by day 35 (Fig. 1 B).
We examined the phenotype of activated and memory 
tetramer+ cells over this period. During activation, the 
  antigen-specifi  c CD4 T cells up-regulated expression of CD44 
and down-regulated CD62L (Fig. 1 C, Day 7). By day 9, all 
Figure 1.  Class II tetramers can be used to enumerate antigen-
specifi  c cells. (A) H19-Env-CFA–immunized mice, three to four per 
group, were killed at various times after immunization, and cells from 
the draining LNs (■) or spleens (▲) were stained with class II tetramers. 
Control mice were immunized with OVA-CFA and stained with the tetra-
mers (▼). The mean percentage of tetramer+ cells out of total CD4 cells 
is shown, and error bars show the SEM. (B) Bone marrow–derived DCs 
were activated with LPS, pulsed with H19-Env or OVA peptide, and 106 
cells were injected i.v. into C57BL/6 mice. At various days after transfer, 
spleens were removed and cells were stained with class II tetramers and 
labeled antibodies (■). The mean percentage of tetramer+ cells out of 
total CD4 cells of four mice per group is shown, and error bars show the 
SEM. Background staining was set by staining cells from mice immu-
nized with OVA-pulsed DCs (▲). (C) Phenotype of tetramer+ cells after 
CFA immunization. Cells gated on CD4+ lymphocytes, excluding prop-
idium iodide+ and F4/80+ cells. First column shows day 7 (primary 
  response), second column shows day 9 (peak of the primary response), 
and the third column shows cells from day 176 after immunization. 
The number shows the percentage of tetramer+ cells that are also 
CD44hi, IL-7Rα+, or CD62Llo.JEM VOL. 203, April 17, 2006  899
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the tetramer+ cells were CD44hi and CD62Llo and they 
maintained this phenotype throughout the memory phase of 
the response.
As IL-7Rα is thought to be a functional marker for the 
precursors of CD8 (14) and CD4 (15, 16) memory cells, the 
kinetics of expression of IL-7Rα was investigated. At day 7, 
before the peak of the response, about half of the tetramer+ 
cells in the draining LN had down-regulated IL-7Rα (Fig. 
1 C, middle). By day 9, although the majority of cells were 
IL-7Rαlo, a substantial proportion was still IL-7Rα+. By day 
14, the majority of tetramer-binding cells in the spleen were 
IL-7Rα+. However, in the draining LN, even by day 32 
only  60% of antigen-specifi  c cells stained positive, presum-
ably refl  ecting continuing activation (from the peptide-CFA 
depot) at this site but not in the spleen (not depicted). All of 
the long-term memory cells (at day 176) at both sites were 
IL-7Rα+, perhaps indicating the importance of this cytokine 
in long-term memory cell survival.
The recall response is faster and larger than 
the primary response
To investigate whether antigen-specifi  c CD4 T cells were still 
present in mice that had been injected with peptide-pulsed 
DCs, these mice were challenged with peptide-CFA. A clas-
sical rapid and large recall response was measured up to 24 wk 
after primary immunization, demonstrating that antigen-spe-
cifi  c memory CD4 T cells were present in these mice (Fig. 2 A). 
However, the size of the recall response was reduced at 
24 wk compared with 13 wk after priming, and by 38 wk 
only two out of six mice made a small recall response to the 
peptide-CFA challenge (Fig. 2 B). This suggests that the 
memory cells declined over time as they had in the peptide-
CFA–immunized mice. In long-term memory experiments, 
age-matched naive control mice were also immunized (not 
depicted). These mice gave similar primary responses to young 
mice, indicating that the loss of memory was not simply an 
age-related impairment of immune function/cell division.
The intensity of tetramer staining is thought to correlate 
with the avidity of the TCR for peptide-MHC (17–19). 
This staining intensity has been found to increase in the recall 
response (18, 20). We also found an increase in the intensity 
of tetramer staining of the responding cells after secondary 
stimulation (Fig. 2 C). This was not observed in memory 
cells that had not been boosted, suggesting that the matura-
tion was a result of selective expansion of higher avidity cells 
during the secondary response. However, this increase in the 
intensity of tetramer staining has also been shown to be due 
to the localization of TCR in rafts rather than an actual in-
crease in the avidity of the interaction between TCR and 
peptide-MHC (21). Regardless, the change in intensity of 
staining indicates a change in the cells involved in the recall 
response compared with those in the primary response, a 
change that may partly explain the increased speed of the 
  recall response.
Figure 2.  The recall response is faster and larger than the primary 
response. C57BL/6 mice were injected with H19-Env–pulsed DCs, rested 
for 13, 24, or 38 wk, and boosted with H19-Env-CFA. Cells from the 
spleens and draining LNs were stained with class II tetramers and ana-
lyzed as in Fig. 1. (A) Example staining of LN cells from the recall response 
after 13 wk, the primary response, and background staining. The number 
shows the percentage of CD44hi tetramer+ cells out of CD4 cells. (B) Per-
centage of tetramer+ cells out of CD4 cells in the LNs of boosted C57BL/6 
mice immunized with DCs, rested for the indicated time, and then boosted 
with H19-Env-CFA and killed on day 5. Day 5, primary response to H19-
Env-CFA; Day 9, peak of the primary response to H19-Env-CFA; OVA, 
background staining from mice primed with OVA-pulsed DCs and boosted 
with OVA-CFA. Each point represents one mouse, and the line shows the 
mean of each group. (C) The intensity of tetramer staining was analyzed 
by defi  ning high and low staining as shown, and the percentage of 
 tetramer+ cells in the high staining box was analyzed.900  COSTIMULATION OF CD4 MEMORY T CELLS | MacLeod et al.
Antigen-specifi  c CD4 T cell priming in CD40KO mice 
is restored by WT DCs
To evaluate the role of the costimulatory interaction between 
CD154 and CD40 in CD4 T cell activation, CD40KO and 
CD154KO and WT C57BL/6 mice were primed with H19-
Env peptide in CFA. As expected, CD4 T cells from WT 
mice bound the tetramer; however, tetramer staining of cells 
from CD40KO or CD154KO mice did not rise above back-
ground at any of the time points examined (Fig. 3 A and not 
depicted for days 15 and 28).
To examine whether priming had occurred at a level 
  below detection by the tetramers ex vivo, splenocytes from 
the mice were activated in vitro with peptide for 4 d. Expan-
sion of antigen-specifi  c cells was detected in splenocytes from 
C57BL/6 mice; however, tetramer staining of the cells from 
CD40KO and CD154KO mice remained at background 
  levels (Fig. 3 B).
We found that the priming could be restored in CD40KO 
mice if they were injected with a cohort of peptide-pulsed 
LPS-activated WT DCs. The primary response in both the 
spleen and draining LN was similar in C57BL/6 and CD40KO 
mice (Fig. 3, C and D). However, in CD154KO mice, in 
which WT DCs cannot restore the genetic defect, tetramer 
staining remained at background levels. The peptide-pulsed 
WT DCs used to immunize CD40KO mice were matured 
with LPS; however, it is clear that this does not bypass any 
requirement for the CD40 signal. In Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20050711/DC1, 
we show that LPS-activated CD40KO DCs could not prime 
T cells in CD40KO mice and, in addition, these mice did 
not respond to antigen delivered with LPS in incomplete 
Freund’s adjuvant.
CD4 memory T cells survive and proliferate after boosting 
in CD40-defi  cient mice
Previous studies have suggested that the activation of mem-
ory cells does not require the same level of costimulation as 
naive cells (22–24). By using WT DCs to restore priming in 
CD40KO mice, a role for CD40–CD154 costimulation in 
the survival and recall response of T cells could be examined. 
Thus, CD40KO mice were immunized with WT LPS-acti-
vated, peptide-pulsed DCs and after 4–18 wk were boosted 
with peptide in CFA. The spleen and draining LN were 
taken on day 5 after the boost. The secondary expansion of 
tetramer+ T cells in the draining LN (Fig. 4, A and B) and the 
spleen (Fig. 4 C) of C57BL/6 and CD40KO mice was abso-
lutely equivalent. Furthermore, in both groups the peak of 
the response at day 5 was dramatically larger than that in the 
primary response in C57BL/6 mice immunized with peptide 
in CFA alone, demonstrating that this was a bona fi  de mem-
ory response.
We next investigated if the memory T cells generated in 
CD40KO mice diff  ered qualitatively from those formed in 
WT mice. We found them to be equivalent in their expression 
of CD44 and CD62L, and they also exhibited the avidity in-
crease (increased intensity of tetramer staining) seen in WT T 
cells (shown in Fig. 2 C). They are also detectable (by staining 
after boost) for a similar length of time after priming in vivo. 
These comparisons of the CD4 memory T cells generated in 
CD40KO and WT mice are shown in Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20050711/DC1.
Tetramer staining slightly above background levels was 
detected in the draining LNs of CD154KO mice that had 
fi   rst been primed with WT DCs and then boosted with 
  peptide-CFA. However, this response was defi  cient compared 
with that in WT or similarly treated CD40KO mice. Thus, a 
small population of memory T cells may be generated in the 
absence of CD40–CD154 interactions.
Differentiation of CD4 memory T cells to produce 
IFN-𝗄 requires CD40
T cell proliferation is only one component of the immune 
response to antigen. To establish whether the restored T 
cell proliferation in the CD40KO mice was accompanied by 
an equivalent cytokine response, the antigen-specifi  c IFN-γ 
Figure 3.  CD40–CD40L signals are required for T cell priming. 
(A) C57BL/6, CD40KO, and CD154KO mice were immunized with H19-Env in 
CFA. 9 d later, spleens and draining LNs were taken and cells were stained 
with class II tetramers. Data from draining LNs are shown with each point 
representing the percentage of CD4 cells that were tetramer+ in an indi-
vidual mouse, and the mean of the group is shown. (B) Splenocytes from 
immunized mice were activated with 1 μg/ml H19-Env peptide. After 4 d 
of culture, the percentage of tetramer+ cells in the CD4+ population was 
measured by FACS. (C) WT DC primed T cells in CD40KO mice. C57BL/6, 
CD40KO, and CD154KO mice were immunized with H19-Env peptide–
pulsed, LPS-matured DCs from WT mice. The percentage of tetramer+ 
cells in the CD4+ population was measured by FACS in the draining LNs 
6 d later. (A–C) Each point represents one mouse, and the line shows the 
mean of each group. Results are representative of three independent 
experiments. (D) Representative FACS dot plots from the experiment 
shown in C. Control mice were immunized with OVA-CFA (A and B) or 
OVA-pulsed DCs (C and D) and stained with the H19-Env tetramers.JEM VOL. 203, April 17, 2006  901
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response was measured. Because TCR levels fall after pep-
tide stimulation in vitro, it was not possible to carry out 
tetramer and intracellular cytokine staining simultaneously. 
Instead, antigen-specifi   c cytokine production from long-
term primed cells was measured after a 6-h in vitro stimula-
tion with peptide using a cell surface cytokine capture assay 
(see Materials and methods). The percentage of CD4 cells 
making IFN-γ in C57BL/6 mice primed with WT DCs 
and boosted with peptide-CFA was signifi  cantly  greater 
than that in similarly treated CD40KO mice (Fig. 5 A; 
P = 0.01). Furthermore, this response was greater than that 
in C57BL/6 mice immunized with peptide-CFA or cells 
from naive mice. In primed and boosted CD40KO mice, 
the percentage of IFN-γ–producing CD4 cells did not rise 
above basal levels (cells incubated without peptide) and did 
not exceed the response of cells from naive C57BL/6 mice. 
Thus, although antigen-specifi  c memory cells proliferated 
in the absence of CD40, these cells were unable to make an 
IFN-γ eff  ector response. Representative FACS dot plots of 
the IFN-γ secretion data shown in Fig. 5 are provided in 
Fig. S3, available at http://www.jem.org/ cgi/content/full/
jem.20050711/DC1. The frequency of tetramer+ CD4 T 
cells producing IFN-γ (in WT mice) is in line with similar 
recently published data (25, 26).
We also tested IFN-γ, IL-2, and IL-4 production after in 
vitro restimulation of spleen or LN cells from immunized 
CD40−/− or WT mice with PMA/ionomycin for 4 h ex 
vivo. The production of IL-2 by total CD4 cells was equiva-
lent in C57BL/6 and CD40KO mice after priming with DCs 
and boosting with CFA (Fig. 5 C). In agreement with the 
antigen-specifi  c IFN-γ response described above, only WT 
mice (and not CD40KO mice) exhibited a signifi  cant in-
crease in IFN-γ–producing CD4 T cells after boosting with 
peptide-CFA (Fig. 5 B; P = 0.008). In summary, the per-
centage of CD4 T cells producing IFN-γ was lower in 
CD40KO mice compared with that in C57BL/6 mice in 
both primary and recall responses (Fig. 5 B). No IL-4–
  producing cells were detected in the response of either 
C57BL/6 or CD40KO mice (not depicted).
The lack of IFN-γ secretion in the absence of CD40 
  during boosting might be due to a dependence of secondary 
eff  ector diff  erentiation on CD40 or, alternatively, it could be 
the result of an impairment in the capacity of the memory 
cells generated in the CD40KO mice to diff  erentiate. To test 
this, we primed CD40KO and WT mice with peptide-pulsed 
WT DCs and then rechallenged them 4 wk later with 
CD40KO (or WT) DCs. This experiment, shown in Fig. 6, 
confi  rmed that memory cells from either WT or CD40KO 
mice required the presence of CD40 on APCs for their dif-
ferentiation to eff  ectors. Thus, the memory cells generated in 
Figure 4.  CD4 memory T cells survive and proliferate after boost-
ing in CD40-defi  cient mice. (A) WT B6, CD40KO, and CD154KO mice 
were immunized s.c. with peptide-pulsed, LPS-matured WT DCs and 
boosted with peptide-CFA after 5 wk. Mice were killed on day 6 after 
boost, and draining LNs and spleens were taken for tetramer staining. 
Each point represents the percentage of tetramer+ cells out of CD4 cells 
in one mouse, and the line shows the mean of each group. One represen-
tative of fi  ve experiments is shown. (B) Representative FACS plots shown 
from the draining LNs of boosted mice, the primary response (mice im-
munized with only peptide-CFA) from the experiment summarized in A. 
Cells gated as in Fig. 1. The number of activated (CD62Llo) tetramer+ cells 
as a percentage of CD4 cells is indicated. One representative of fi  ve 
  experiments is shown.
Figure 5.  Effector cytokine production is reduced in CD40KO 
mice. Splenocytes from C57BL/6 and CD40KO mice primed with WT DCs 
and boosted with peptide-CFA were activated in vitro with peptide (A) or 
PMA/ionomycin (B and C). In A, the IFN-γ–producing cells were detected 
by cell surface cytokine capture assay and in B and C by intracellular 
  cytokine staining. The percentages of total CD4 cells producing either 
IFN-γ (A and C) or IL-2 (B) are shown. Each point represents one mouse, 
and the line shows the mean of each group. Data are representative of 
three (A) or four (B and C) experiments.902  COSTIMULATION OF CD4 MEMORY T CELLS | MacLeod et al.
CD40KO mice diff  erentiated into IFN-γ producers when 
restimulated with WT DCs, whereas the memory cells 
formed in WT mice diff  erentiated very poorly when boosted 
with peptide-pulsed CD40KO DCs.
DCs but not B cells are required for effector T cell 
differentiation recall responses
We wished to confi  rm the identity of the CD40-bearing 
APCs in vivo necessary for eff  ector T cell diff  erentiation. 
We (27) and others (28) have proposed that B cells are parti-
cularly important in maintaining or supporting memory CD4 
T cell responses, and we set up bone marrow chimeric mice 
in which the CD40 mutation was restricted to B cells (29). In 
these chimeras, activated T cells could interact via CD40 
with DCs and macrophages, but not with B cells. The per-
centage of tetramer+ T cells activated after the transfer of 
peptide-pulsed WT DCs was the same in B cell CD40KO 
chimeras as in WT chimeras (Fig. 7 A). As expected, the re-
call response was also similar in the two sets of chimeras after 
boosting with H19-Env-CFA (Fig. 7 B).
The IFN-γ response after priming with WT DCs was 
equivalent in CD40KO B cell chimeras and WT chimeras 
(Fig. 7 C). Similarly, in CD40KO B cell and WT chimeras, 
which had been immunized with DCs and boosted with 
H19-Env-CFA after 10 wk, the number of IFN-γ–secreting 
CD4 T cells was similar (Fig. 7 C). Thus, interactions with 
DCs are suffi     cient to restore the defect in the secondary 
  eff  ector cell response.
DISCUSSION
Tracking memory cells using MHC class II tetramers led us to 
investigate the requirements for costimulatory signals in T cell 
responses in vivo. There have been reports that memory cells 
require less costimulation than naive cells; however, the ma-
jority of these experiments have been performed in vitro (22, 
23, 30). The fi  ndings reported here validate these studies, and 
advance them as the current data is derived entirely ex vivo.
Normal immunization of CD40-defi  cient mice fails to 
evoke clonal expansion of naive CD4 T cells; however, by 
transferring WT DCs into CD40KO mice, primary and re-
call responses were restored. This demonstrates several 
points: (a) The T cells activated in CD40KO mice in re-
sponse to WT DCs developed into memory cells; (b) these 
memory cells survived in a CD40-defi  cient environment; 
(c) the memory T cells were able to proliferate in response 
to antigen rechallenge in the absence of CD40, demonstrat-
ing a qualitative diff  erence between naive and memory CD4 
T cells; and (d) the memory cells could not, however, dif-
ferentiate to produce eff   ector cytokines without CD40–
CD154 signals.
That antigen-specifi  c cells were not detected after immu-
nization of CD40KO and CD154KO mice with peptide-
CFA could be due to several factors. Moodycliff  e et al. (31) 
have reported a requirement for a CD154 signal to DCs in the 
skin to induce their migration to draining LNs. This seems an 
improbable explanation for our data, as we were able to see 
presentation of antigen in the recall response in CD40-
  defi  cient mice. Indeed, free antigen is likely to reach lymphoid 
organs by draining from the immunization site (32, 33).
The most likely explanation for the defect of priming in 
CD40KO mice is that the T cell–DC interaction may be 
curtailed in the absence of this maturation signal to the APCs. 
The adoptive transfer and immunization of CD154-defi  cient 
TCR transgenic T cells into WT mice, or the transfer of 
  antigen-pulsed CD40-defi  cient DCs to WT mice, results in 
a brief proliferative response followed by a crash of the trans-
genic T cells (6, 10, 11). Miga et al. (10) argue that the CD40 
signal to the DCs is required for the full activation of the 
DCs. For example, CD40–CD154 signals induce increased 
expression of costimulatory molecules such as CD80 and 
CD86 and, importantly, also greatly enhance DC IL-12 pro-
duction (4, 5, 34). It is also likely that T cell activation in vivo 
in the absence of CD40 is impaired because of a failure of 
OX40L signals (11, 29, 35, 36).
Figure 6.  Recall IFN-𝗄 secretion is dependent on CD40. WT or 
CD40KO mice were immunized with H19-Env peptide–pulsed, LPS-
  matured WT DCs. 4 wk later, the mice were boosted with peptide-
pulsed, LPS-matured DCs from WT or CD40KO mice as indicated. 
Antigen-specifi  c cells were detected by tetramer staining (A), and the 
frequency of peptide-induced IFN-γ–secreting cells was measured 
by the cell surface cytokine capture assay (B). All mice were boosted 
with peptide in CFA at 2 wk. Each point represents one mouse, and the 
line shows the mean of each group. Data are representative of two 
such experiments.JEM VOL. 203, April 17, 2006  903
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Immunization with WT DCs circumvented this defect. 
Antigen-specifi  c CD4 T cells in the CD40KO mice prolifer-
ated to the same level as in WT mice. These primed T cells 
were indistinguishable in phenotype from memory cells gen-
erated in WT mice and survived in the CD40-defi  cient en-
vironment for at least 18 wk (Fig. S2). When reimmunized 
with peptide plus CFA they responded by proliferating just as 
well as memory cells in WT mice (Fig. 4). However, they 
were incapable of diff   erentiating into IFN-γ–producing 
  eff  ector T cells. So the costimulation requirements of mem-
ory cells for cell division are less stringent than naive cells, but 
diff  erentiation still requires some, if not all, of the same co-
stimuli. The importance of B cells in supporting this diff  eren-
tiation was investigated using bone marrow chimeras given 
our previous data suggesting a dependence of CD4 T cell 
memory on B cells (27). The observation that the eff  ector 
(IFN-γ) response is restored if CD40+ DCs are present rules 
out any obligatory CD40-dependent role for B cells. More-
over, WT bone marrow–derived DCs were suffi   cient to re-
store the IFN-γ response in DC-primed CD40KO mice. 
This demonstrates, using two immunization protocols, that 
DCs play an important role as APCs in the CD4 recall re-
sponse, as they do in CD8 recall responses (37).
The requirement for CD40–CD154 interactions for CD4 
memory T cell diff   erentiation observed here may be ex-
plained in three ways. First, continued signaling via CD40 on 
host APCs may be required during the primary response. In 
such a model, this continued signaling would then imprint 
the capacity of the expanding CD4 T cell population to dif-
ferentiate into eff  ector cells during the recall phase. Second, 
CD40–CD154 interactions may be required during the 
memory phase to maintain the capacity of memory T cells to 
diff  erentiate upon renewed antigen encounter. Finally, and 
perhaps most likely, memory CD4 T cells may proceed 
through cell division independently of CD40–CD154 inter-
actions but would still require this interaction for functional 
maturation. In this model, DCs would have the capacity to 
control memory T cell responses not through regulation of 
memory T cell expansion, but by licensing memory helper T 
cells for eff  ector cell diff  erentiation. This fi  nal interpretation 
is strongly supported by the observation that memory cells 
generated in WT mice diff   erentiated only poorly when 
boosted with peptide-pulsed CD40KO DCs and, conversely, 
memory cells formed in CD40KO mice could diff  erentiate 
into IFN-γ producers perfectly well when restimulated with 
WT DCs (Fig. S3). The licensing or programming may be 
mediated by infl  ammatory cytokines, such as IL-12 (38). Al-
though we have presumed in these explanations that it is 
CD40 activation of APCs that is critical, we cannot rule out 
a role for CD40 that may be expressed by the CD4 T cells 
themselves (39).
The immunization of CD40KO mice with peptide-
pulsed DCs gives rise to negligible IFN-γ production in the 
primary response (Fig. 5 B), even though clonal expansion is 
instigated and the cells survive into the memory phase and 
can be reactivated many weeks later. This is a clear indication 
that memory cells can be generated without passage through 
the eff  ector cell stage. This linear development of memory 
cells from eff  ector cells has been suggested by several recent 
publications (40–42). As most lineage studies so far published 
refer to CD8 T cells, this may simply represent a diff  erence 
between CD4s and CD8s. On the other hand, it is more 
  attractive to suppose that there are several ways to generate 
the diff  erent memory cell subsets. In the circumstance pre-
sented here, subnormal quality or quantity of stimulus allows 
Figure 7.  CD40-bearing B cells are not essential in the recall 
  cytokine response. Mixed bone marrow chimeras were made as described 
in Materials and methods, such that the B cell compartment lacked CD40, 
whereas the majority of the DCs were CD40 suffi  cient. 8 wk after recon-
stitution, WT and B cell CD40KO chimeras were immunized s.c. with pep-
tide-pulsed DCs. (A) Percentage of tetramer+ cells out of CD4 cells in 
C57BL/6 and CD40KO B cell chimeras primed with WT DCs s.c. Spleens 
and draining LNs were taken on day 7 and stained with class II tetramers. 
(B) Percentage of tetramer+ cells out of CD4 cells after priming with DCs 
and boosted with H19-Env-CFA after 10 wk. (C) Percentage of CD4 cells 
producing IFN-γ in the primary and secondary response after incubation 
in vitro with PMA/ionomycin as in Fig. 5 (B and C). Each point represents 
one mouse, and the line shows the mean of each group. Results are 
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long-term memory cells, but no eff  ectors, to develop, repre-
senting a divergent pathway of diff  erentiation (43).
The tetramer-binding memory cells in this study are ho-
mogeneous and stable in their expression of molecules that 
would mark them out as eff  ector memory cells (e.g., CD62Llo, 
CD44hi). This homogeneity in marker expression is contrary 
to studies by Roman et al. (44) and Ahmadzadeh et al. (45), 
who have described heterogeneity within an antigen-specifi  c 
memory pool based on CD62L staining. There are various 
diff  erences between these studies and ours, including the use 
of TCR transgenic T cells as well as the presence of CFA-
peptide depots to provide a potential for continued activa-
tion of cells. However, it is of interest in this context that 
Marzo et al. (46) have recently found that at low precursor 
frequency (e.g., in endogenous T cell populations) the 
  eff  ector–memory CD8 population is predominant and stable 
over long periods.
The expression of the α-chain of the IL-7R (IL-7Rα) is 
also stable on our long-term tetramer-binding CD4 memory 
cells (98%; Fig. 1 C). It is interesting that at the peak of the 
primary expansion (day 9) only a minority (19%; Fig. 1 C) of 
the tetramer+ memory cells bear IL-7Rα (down from 55% 
2 d earlier). On the face of it, this fi  ts with the notion that re-
activity to IL-7 marks out the memory precursors that will 
survive the contraction phase and move into the memory 
pool (14–16). However, it takes more than 30 d for the ma-
jority of the tetramer+ memory cells to express IL-7Rα (61% 
at day 32; not depicted), an indication that entry into the 
CD4 memory pool is not absolutely dependent on IL-7R, 
a point recently made by Lacombe et al. (47).
Using the MHC class II peptide tetramers, antigen-
  specifi  c CD4 memory T cells were visible ex vivo more than 
200 d after immunization with peptide plus CFA, and recall 
responses were detectable for more than 150 d after immuni-
zation with peptide-pulsed DCs. After this time, these poly-
clonal CD4 memory T cells would undergo signifi  cant 
secondary clonal expansions upon antigen restimulation, in 
contrast to the relatively poor secondary expansion observed 
with transferred TCR transgenic CD4 memory T cells (48). 
Our longitudinal studies tracking antigen-specifi  c memory 
cells in mice immunized with either peptide in a persistent 
form (with CFA) or with a transient exposure (peptide-pulsed 
DCs) also demonstrated a slow decline in CD4 memory T 
cell survival over time. A similar decrease in CD4 memory 
cells was described by Homann et al. (49), although there 
have been reports of stable CD4 memory pools (50, 51). It is 
no surprise to us that under competitive conditions memory 
cells decay and do not survive indefi  nitely (52). Despite this, 
the basis of the homeostatic loss under these normal competi-
tive conditions still needs resolution.
MATERIALS AND METHODS
Mice. C57BL/6, CD40KO (53), and CD154KO (54) were bred and main-
tained in specifi  c pathogen-free conditions at the School of Biological Sci-
ences, Animal Facility at the University of Edinburgh. 6–10 wk old mice 
were age and sex matched in experiments. All experiments were covered by 
a Project License granted by the Home Offi   ce under the Animal (Scientifi  c 
Procedures) Act of 1986. Locally, this license was approved by the Univer-
sity of Edinburgh Ethical Review Committee.
Immunizations. Mice were immunized with 100 μg H19-Env (E  P  L  T  S  L-
T  P  R  C  N  T  A  W  N  R  L  K  L  ) or OVA323–339 peptide (I  S  Q  A  V  H  A  A  H  A  E  I  N  E  A-
G  R  ) that binds to H2-Ab (both were made and supplied by Advanced 
Biotechnology Centre, Imperial College, London). The peptides were 
emulsifi  ed in CFA (Sigma-Aldrich) and injected s.c. in both hind legs. For 
bone marrow–derived DC immunizations, mice were injected with 106 
DCs either i.v. in the tail vein or s.c. in the hind legs. In recall experiments, 
mice were fi  rst primed with peptide-pulsed DCs s.c., boosted with peptide-
CFA when indicated, and killed on day 5. All injections were in the hind 
leg. In one experiment, LPS (from Salmonella typhimurium; Sigma-Aldrich) 
was used as adjuvant. It was delivered (at 30 μg/mouse) together with 
  peptide in incomplete Freund’s adjuvant.
Tetramer and antibody staining. Single cell suspensions were prepared 
from spleens and inguinal LNs, and erythrocytes were lysed using Red Blood 
Cell Lysis Solution (Sigma-Aldrich). Approximately 1–2 × 106 cells were 
plated in round-bottom 96-well plates and washed in IMDM (Sigma-
  Aldrich) containing 10% FCS before the addition of PE-labeled class II tetra-
mers diluted in IMDM plus 10% FCS. Tetramers were made as described 
previously (17). The cells were incubated at 37°C for 3 h with gentle agita-
tion every 20–30 min to prevent clumping of cells. Allophycocyanin (APC)-
labeled anti-CD4 (BD Biosciences), R. Phycoerythrin–Cy5-labeled 
anti-F4/80 (Serotec), and FITC-labeled anti-CD44 (142.5; in-house) or 
FITC-labeled anti-CD62L (MEL-14; in-house) or FITC-labeled anti–IL-
7Rα (CD127; eBioscience) were added and incubated for 10–15 min at room 
temperature. Cells were washed three times in FACS buff  er (PBS with 2% 
FCS and 0.05% sodium azide). Propidium iodide (BD Biosciences) was added 
before acquisition. 200,000 live events were collected on a FACSCalibur 
fl   ow cytometer (Becton Dickinson) and analyzed using FlowJo software 
(TreeStar). Viable lymphocytes were defi  ned using FSC/SSC parameters 
and propidium iodide exclusion, and tetramer+ cells were identifi  ed as CD4+ 
F4/80− live lymphocytes.
Bone marrow–derived DCs. DCs were derived from bone marrow cells 
according to the procedure developed by Inaba et al. (55). A single cell sus-
pension of the bone marrow from the femurs and tibias of 6–10-wk-old WT 
C57BL/6 or CD40KO mice was prepared and red blood cells were lysed. 
Cells were plated in 24-well plates at 3.75 × 105 in 1 ml in 10% FCS, 5% 
GM-CSF (supernatant from a GM-CSF–producing cell line; reference 56), 
and RPMI medium (Sigma-Aldrich) supplemented with 2 mM l-glutamine, 
100 U/ml penicillin, and 100 μg/ml streptomycin (all from Invitrogen). 
Cells were grown for 7 d and washed on days 3 and 6, with the FCS in the 
medium being replaced with 0.5% mouse serum (Harlan UK).
DCs were harvested on day 7, incubated at 37°C together with 0.1 μg/ml 
LPS (Sigma-Aldrich) for 12–13 h, and then reharvested. The DCs were 
  incubated for 90 min with 50 μg/ml peptide and washed extensively with 
PBS before injection into mice.
In vitro activation. Single cell suspensions, prepared as described above, 
were plated in 96-well plates at 106 cells per well and incubated for 3 d 
at 37°C and 5% CO2 with 1 μg/ml H19-Env peptide in IMDM supple-
mented with 5% FCS, 2 mM l-glutamine,100 U/ml penicillin, 100 μg/ml 
streptomycin (all from Invitrogen), and 50 μM 2-mercaptoethanol (BDH 
Laboratories).
Detection of antigen-specifi  c  IFN-𝗄. Single cell suspensions were 
  prepared as described above, and splenocytes were cultured with 8 μg/ml 
H19-Env peptide for 6 h (or without peptide) at 37°C and 5% CO2 in 
RPMI containing 1% mouse serum supplemented with 2 mM l-glutamine, 
100 U/ml penicillin, and 100 μg/ml streptomycin. The production of IFN-γ 
was then assessed using an IFN-γ capture and detection kit (Miltenyi Biotec) 
according to the manufacturer’s instructions. In brief, the cells were harvested, JEM VOL. 203, April 17, 2006  905
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washed, and incubated with the bi-specifi  c capture antibody (anti-CD45–
anti-IFN-γ). Extra medium was added to the cells that were then incubated 
for an additional 45 min in the MACSmix to rotate the cells throughout the 
incubation period. After additional washes, the cells were stained with 
PE-labeled detection anti–IFN-γ and anti–B220-PerCP (BD Biosciences), 
and anti–CD4-APC and anti–CD44-FITC. Propidium iodide (BD Biosciences) 
was added before acquisition. 500,000 live events were collected on a 
  FACSCalibur fl  ow cytometer and analyzed using FlowJo software. IFN-γ–
producing CD4 cells were identifi  ed by gating out B cells and dead cells (all 
FL3+ cells), and gating on CD4+ cells.
Intracellular cytokine staining. Cells were plated at 4–5 × 106 cells per 
well in 24-well plates and incubated for 4 h with 10 ng/ml PMA and 1 μg/ml 
ionomycin (both from Sigma-Aldrich) in the presence of Golgi Stop   (Becton 
Dickinson). Cells were transferred into V-shaped 96-well plates and washed 
with FACS buff   er before staining at 4°C with APC-labeled anti-CD4 
(BD Biosciences) for 15 min. After washing, cells were fi  xed for 20 min with 
Cytofi  x and then washed in Cytoperm (Becton Dickinson). Anti-cytokine 
antibodies (anti–IL-2–PE and anti–IFN-γ–FITC; BD Biosciences) diluted 
in Cytoperm were added for 45 min. The cells were washed in Cytoperm 
three times, resuspended in PBS, and acquired on a FACSCalibur.
Bone marrow chimeras. Recipient mice were lethally irradiated with 
1150c Gy from a Caesium γ source 24 h before bone marrow reconstruc-
tion as described previously (29). Bone marrow was removed from donor 
mice and depleted of T cells using anti-Thy1 microbeads on a MACS 
magnetic column (both from Miltenyi Biotec) according to the manufac-
turer’s instructions. Between 3 and 5 × 106 cells were injected into the 
  irradiated recipients.
Mixed chimeras were made by reconstituting with 80% μMT (B cell–
defi  cient) bone marrow and 20% CD40KO bone marrow. B cells can only 
develop from the CD40KO bone marrow and were therefore CD40 defi  -
cient. Control WT chimeras were made with 80% μMT bone marrow and 
20% C57BL/6 bone marrow. The chimeric hosts were then left for 8 wk to 
allow full reconstruction from the donor cells. Reconstitution was con-
fi  rmed by FACS analysis of splenocytes when the chimeras were killed.
Statistics. Data are expressed, when appropriate, as mean and SEM. Signifi  -
cance was assessed using unpaired t tests, and p-values <0.05 were consid-
ered signifi  cant.
Online supplemental material. Fig. S1 shows that the priming of CD4 
T cells in CD40KO mice cannot be bypassed by LPS signals alone. Fig. S2 
shows a comparison of phenotype, avidity, and longevity between memory 
CD4 T cells generated in WT and CD40KO mice. Fig. S3 shows represen-
tative fl  ow cytometry dot plots of cytokine (IFN-γ) secretion by secondary 
eff  ector cells in WT and CD40KO mice. Figs. S1–S3 are available at http://
www.jem.org/cgi/content/full/jem.20050711/DC1.
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